The Iran nuclear deal is merely the cornerstone of a broader, longer-term strategy to prevent Iran from obtaining a nuclear weapon and to diminish and counter Iran’s threatening behavior—from its growing ballistic missile arsenal, to its dangerous use of regional proxies, to its human rights abuses at home.
How the United States can confront challenges by vigorously enforcing the JCPOA despite the non-certification decision, while also taking additional steps to limit Iran’s nuclear and regional activities, and engage Iran economically and diplomatically.
Despite some arguments to the contrary, limits on Iran’s enrichment capabilities are consistent with the 2002 U.S. law regulating medical isotope production.
Escalating tensions surrounding the Kurdish independence referendum are encouraging Iran to accelerate efforts to diversify trade to Iraq.
U.S. President Donald Trump’s threats to undo the Iran Nuclear Deal hands leverage over to Iran, and reduces international confidence in the United States.
The Nobel Committee awarded its annual peace prize to the laudable goal of nuclear disarmament. But civil society actors and governments concerned about disarmament should not be tempted to rest on the laurels of this achievement.
European companies are doing business in Iran, undeterred by Trump’s rhetoric. This is surely a reason for the United States to be concerned about its own future influence.
U.S. President Donald Trump’s speech on the Iran deal and Tehran’s activities in the region reflects a tough-minded approach with objectives that are at best unclear and likely unrealistic.
A tracker that presents each allegation of non-compliance made by the Trump administration and assesses them.
Every one of the very real challenges Iran poses in the world would be made more difficult to manage if Iran were freed of the nuclear limits agreed in the JCPOA, and every one of them would be made more difficult if the United States isolates itself from its partners.